Cadenza Bio
PrivateLast Round
Seed
Dec 14, 2023
Total Funding Raised
$2.44M
Momentum Score
25 /100
Company Overview
Cadenza Bio, Inc. is a biotechnology company that develops novel small-molecule drugs for demyelinating and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cadenza Bio Comps
Public and private peers based on sector, stage, and business model.
Cadenza Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 14, 2023 |
Cadenza Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oklahoma Life Science Fund | Seed |
| Plains Ventures | Seed |
| Boyd Street Ventures | Seed |
| Cortado Ventures | Seed |
| Illinois Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 7, 2025
Partnered with Tufts University to advance endometriosis program.
Cadenza Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cadenza Bio's valuation, stock price, and market status.
